SUMMARY. Red blood cell magnesium concentrations were measured in samples from 89 patients who fulfilled the diagnostic criteria for chronic fatigue syndrome and the results compared to those found in an age and sex matched group selected from the normal population. No significant difference was found. Six patients were further investigated using a magnesium loading test to determine if there was any evidence of magnesium deficiency associated with this disorder. None was found. There is therefore no indication for the use of magnesium therapy in the management of this condition.
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Chronic fatigue syndrome (CFS) is a condition characterized by a variety of symptoms but mainly fatigue and myalgia. 1-3 A previous study suggested that patients with CFS suffer from magnesium deficiencyand that replacement therapy would therefore be appropriate." However, other workers have failed to substantiate these results." In both of these studies only a small number of patients were investigated and the erthrocyte magnesium concentration was used as the only indicator of total body magnesium. In a later study where magnesium loading was used to assessmagnesium status no evidenceof magnesium deficiency was found; the study had 12 patients and six controls."
Magnesium salts are poorly absorbed by mouth and if oral replacement therapy is used the response is often delayed and suboptimal. Magnesium salts are well known purgatives and oral supplementation often results in diarrhoea. While parenteral therapy ensures a rapid correction of any deficiency, the risk of overdose must be always borne in mind. A variety of side effects and life threatening complications have been described in patients on parenteral magnesium Correspondence: Dr D R McCluskey. therapy including muscle paralysis and cardiac conduction abnormalities," It is therefore of vital importance before embarking on this treatment that there is definite evidence of deficiency and that blood concentrations are monitored.
We report a study of 89 patients and 89 age and sex matched controls in whom erthrocyte magnesium concentrations were determined and, in addition, we report the results of intravenous magnesium loading tests in six patients. We could find no evidence of magnesium deficiency in patients with CFS.
PATIENTS AND METHODS
Patients fulfilling the Centers for Disease Control and Prevention (CDC) criteria for CFS 8 were identified from a population attending the regional immunology clinic at the Royal Victoria Hospital and age-sex matched controls were obtained from the Belfast Monica project? which recruits at random from the Northern Ireland population.
Eighty-nine CFS patients were recruited (61 female and 28 male) with a mean age of 40·3 years (range 19-64 years). The control population had a mean age of 41·1 years (range 19-64 years). Blood samples were taken by venesection and collected in potassium EDTA tubes which had previously been screened for magnesium contamination. A portion of whole blood was frozen and the remainder spun at 2600 x g for 10 min. The samples from cases and controls were analysed side by side with the plasma and whole blood samples diluted (l/6l and 1/102, respectively) with 0·2070 HN0 3 and nebulized directly into an air/acetylene flame for atomic absorption measurements at 285 . 2 nm. Standards used to calibrate the instrument were O·2 and 0·4/Lg/mL diluted with O' 2% HN0 3 , using a stock solution of 1000 /Lg/mL magnesium in 0·1 N HCl (Hopkins and Williams reagent for atomic absorption spectrophotometry). The erthrocyte magnesium concentration (RBC Mg) was calculated from the formula:
RBC Mg=P+(IOO[W-P]IH)
where P = plasma, W = whole blood magnesium and H = packed red cell volume (%).
An intravenous magnesium loading test was performed on six CFS patients. Patients were admitted as day cases or overnight and blood was taken to provide a baseline red cell magnesium concentration. An infusion of 30 mmol magnesium sulphate in 1 L of normal saline was given over 8 h. Urine was collected for 24 h from the commencement of the infusion and total magnesium excretion determined using atomic absorption spectrophotometry to determine the urinary concentration.
RESULTS
Mean erthrocyte magnesium concentrations in patients with CPS and controls were 1. 93 mmollL and 1·91 mmol/L, respectively (Table 1) . This difference was not significant using the two tailed t-test (P=0·74) .
The results of the magnesium loading tests showed that the patients excreted 23-30 mmol (76-100%) of magnesium in the 24 h period following an intravenous infusion of 30 mmol of magnesium sulphate ( Table 2 ). This is within the normal range for this test since less than 60% excretion is needed to indicate a state of magnesium depletion. 10 
DISCUSSION
Magnesium is one of the most abundant intracellular cations and is essential for the transport, storage and utilization of intracellular energy and for normal cell membrane function and neuromuscular transmission. Magnesium deficiency is characterized by electrolyte imbalance, cardiac arrhythmias, neuromuscular dysfunction and neuropsychiatric symptoms. The clinical features of fatigue, myalgia, palpitations, paraesthesia and depression are also present in patients with CFS, resulting in the suggestions that deficiency of this cation may cause the disorder and that replacement therapy may be beneficial. However, the evidence that magnesium deficiency occurs in patients with chronic fatigue syndrome has been limited to one small study of 20 patients! Only 11170 of total body magnesium is present in extracellular fluid, and 301170 of this is protein bound. The vast majority of magnesium is contained within bone, muscle and other body tissues. Serum and red cell magnesium measurements, while relatively simple to perform, are not the most sensitive or accurate tests for magnesium deficiency. In this study we found no difference between the red cell magnesium level in subjects with CFS and 89 healthy controls which confirms the findings of Deulofeu et al. 5 and is contrary to those of Cox et al,"
A study of hypomagnesaemia in chronic alcoholics'? established the magnesium loading test as the most reliable and sensitive test to differentiate patients deficient in magnesium from a reference group. Individuals with normal magnesium stores excrete more than 601170 of the administered load of 30 mmol MgS0 4 within 24 h. All six CFS patients excreted more than 761170 of the infused magnesium, indicating that none had any significant magnesium deficiency.
We conclude that magnesium deficiency is not a feature of CFS, and that the estimation of red cell magnesium is of no benefit in its diagnosis or assessment. Thus, there is no indication for magnesium supplementation in CFS patients.
